
BERNING
Mr. Berning is an entrepreneur with over 20 years of experience managing technology start-ups. Mr. Berning was the CEO of Hardcore Computer/Liquid Cool Solutions from 2007 to 2012. Prior to Liquid Cool Solutions Mr. Berning was CEO and Chairman of the Board of PEMSTAR from its founding in 1994. Mr. Berning led PEMSTAR to an IPO on NASDAQ in 2000 and its merger with Benchmark Electronics. In the early part of his career, Mr. Berning held numerous positions in management and engineering at IBM. He has sat on numerous boards including the Greater Rochester Area University Center, United Way of Olmsted County and the Advisory and Advocacy Board of the University of Minnesota Rochester. Mr. Berning received his M.B.A. and B.S. in industrial engineering from St. Cloud University.






























Ambient Clinical Analytics has achieved U.S. Food and Drug Administration FDA Class II clearance for its AWARETM point of care platform and was built by clinicians for clinicians. The solution is designed for data collection, presentation, management and storage of patient information, used in conjunction with independent patient bedside devices and Hospital Information Systems. AWARETM is indicated for use in clinical care of hospitalized adult, pediatric, and neonatal patients (Newborn, infant, child, and adolescent) with or at risk of critical illness.
Ambient Clinical Analytics has been granted CE Marking certification for the AWARETM software platform. CE marking is a certification mark that indicates conformity with health, safety, and environmental protection standards for products sold within the European Economic Area (EEA). CE Marking certification in addition to achieving FDA Class II clearance and ISO 13485:2016 certification continues to demonstrate Ambient Clinical Analytics’ is a world-class business delivering value and long-lasting support.
Ambient Clinical Analytics is pleased to announce that it has achieved ISO 13485:2016 certification, an internationally recognized quality standard specific to the medical device industry. The ISO 13485 standard is an internationally agreed standard that sets out the requirements for a quality management system specific to the medical device industry. ISO certification communicates a message to all potential provider healthcare partners that certified companies are world-class businesses capable of delivering value and long-lasting support. By becoming ISO certified, a company is able to demonstrate through time they have met the objectives of a rigorous standard of excellence which is extremely important to health systems and will enhance their competitive advantage.